Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pathogen-specific Bacteriophage Therapeutics
100,0
%
| 6 | 100,0 % | 5 | 100,0 % | -17,77% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States and Australia
100,0
%
| 6 | 100,0 % | 5 | 100,0 % | -17,77% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 11/07/23 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 26/10/20 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Richard Rychlik
AUD | Comptroller/Controller/Auditor | 68 | 05/09/23 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 64 | 12/02/20 | |
Joseph Patti
BRD | Director/Board Member | 60 | 09/05/19 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 01/04/21 |
Odysseas Kostas
BRD | Director/Board Member | 49 | 12/02/20 |
Robin Kramer
CHM | Chairman | 58 | 08/12/20 |
Todd Peterson
BRD | Director/Board Member | 66 | 10/10/19 |
Deborah Birx
CEO | Chief Executive Officer | 68 | 11/07/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 36 154 617 | 10 746 770 ( 29,72 %) | 0 | 29,72 % |
Coordinate società
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+51,85% | 57,87 Mrd | |
+41,42% | 40,25 Mrd | |
-5,25% | 39,94 Mrd | |
-5,16% | 28,54 Mrd | |
+12,79% | 26,4 Mrd | |
-20,18% | 19,33 Mrd | |
+30,88% | 12,4 Mrd | |
+0,61% | 12,23 Mrd | |
+25,06% | 12,2 Mrd |